Eric Halioua, President & CEO of PDC*line Pharma will be a panelist in the Advances in Cell & Gene Therapies round table at the 11th Annual European Life Sciences CEO Forum. A Sachs Associates event...

Events

PDC*line Pharma CEO and COO will be in San Francisco (USA) during the JP Morgan conference, January 8–10, 2017.

Events

PDC*line Pharma’s CMO and CSO will be present at ESMO Immuno Oncology Congress in Geneva, Switzerland – 07 Dec – 10 Dec 2017. A poster will be presented describing our last results with Neo-Antigens....

Events

Eric Halioua, President & CEO of PDC*line Pharma will be chairman at a roundtable session on “How to keep the founding scientists committed?” at BioFIT partnering event, Strasbourg (France) , November...

Events

Eric Halioua, President & CEO of PDC*line Pharma will be chairman at a roundtable session on “Next generation therapeutic vaccines : viral, bacterial and cell based” at World Immunotherapy Congress in...

Events

Eric Halioua, President & CEO of PDC*line Pharma will present the company at the Sachs Associate 17th Annual Biotech in Europe Forum in Basel Wednesday September 27th.

Events

Eric Halioua, CEO of PDC*line Pharma will be speaker at an official satellite workshop at BIO US (San Diego, CA – US) to present the company strategy for new immunotherapies. The workshop entitled “Wi...

Press releases

We are very pleased to inform you that the 8th edition of MATWIN’s international board has awarded PDC*line Pharma with the prize of most promising project in the “start-up” category.

This prize...

Press releases

Three Belgian investment funds and several specialized international business angels have participated in this round, which will allow the company’s cancer immunotherapy technology to reach the...

Press releases

PDC*line Pharma will attend BIO-Europe in Cologne (Germany)
November 7–9, 2016
Cologne, Germany
Let’s meet there !

Events